Ben Millette (@ben_millette) 's Twitter Profile
Ben Millette

@ben_millette

Consultant in Intensive Care and Anaesthesia, Trust POCUS lead, Sportsman, Cinephile, Mexican food aficionado

ID: 793115556375367680

calendar_today31-10-2016 15:40:59

2,2K Tweet

1,1K Followers

511 Following

Jason (@dr_jsa) 's Twitter Profile Photo

It'll never be proven, because it isn't measurable, but the fall in NHS productivity is at least partly down to the loss of goodwill and discretionary effort from staff. The culture around working when unwell and staying behind (rightly IMO) is night and day from when I started.

Ben Millette (@ben_millette) 's Twitter Profile Photo

Watching how people secure lines, drains etc there is a real need for anaesthetists/intensivists to learn the basic surgical skill of one handed knot tying Excellent video here: youtu.be/uFJbTbjeU4Y?si…

Peter Nydahl (@nydahlpeter) 's Twitter Profile Photo

Unheard and unseen: The hidden impact of nocebo communication in the Intensive Care Unit Short review, makes you think before you start talking at the bedside journals.sagepub.com/doi/full/10.11…

Ben Millette (@ben_millette) 's Twitter Profile Photo

Fascinating to hear results of the BLING III trial at #ccr24 More pts than all the other trials combined! No statistically significant diff in 90d mortality BUT SRMA published simultaneously demonstrates mortality benefit with NNT 26 to prevent 1 death πŸ€” jamanetwork.com/journals/jama/…

Ben Millette (@ben_millette) 's Twitter Profile Photo

#A2Btrial results provide lots of food for thought! No benefit on duration of MV. Increased agitation in alpha 2 agonist groups is a bit unexpected. Dex group extubated a day earlier than propofol group; not statistically significant but potentially clinically significant? #CCR24

Ben Millette (@ben_millette) 's Twitter Profile Photo

Big takeaway from #A2Btrial : sedation trials are REALLY HARD TO DO! No clear benefit in using alpha 2 agonist routinely but big remaining question is whether these agents have a role in patients with agitated delirium (as in DAHLIA trial) #CCR24 pubmed.ncbi.nlm.nih.gov/26975647/

Ben Millette (@ben_millette) 's Twitter Profile Photo

A lot to unpack in DEFENDER trial results. Need to get my head around the concept of win ratio! Perhaps not surprising that there was no benefit in a generally critically ill population. Most interesting thing for me is zero euglycaemic DKA cases! #CCR24 jamanetwork.com/journals/jama/…

Resident Doctors (@bmaresidents) 's Twitter Profile Photo

We're aware that many doctors are being told their training is being automatically extended due to exceeding TOOT thresholds. This should NOT happen. GMC and NHS England confirm there should be no automatic extensions. See our guidance on TOOT πŸ‘‡ bma.org.uk/toot-ia

Ben Millette (@ben_millette) 's Twitter Profile Photo

Great thread! Reminds me of an old talk by Merv Singer about the misinterpretations of lactate where he said "lactate gets a bad rap but it's a good guy!"

NephroPOCUS (@nephrop) 's Twitter Profile Photo

#VExUS Score at Discharge as a Predictor of Readmission in Patients with Acute Decompensated #HeartFailure: A Cohort Study πŸ”— scielo.br/j/abc/a/MQdGqP…

#VExUS Score at Discharge as a Predictor of Readmission in Patients with Acute Decompensated #HeartFailure: A Cohort Study
πŸ”— scielo.br/j/abc/a/MQdGqP…
Nick Mark MD (@nickmmark) 's Twitter Profile Photo

New favorite physiology paper: Central Venous Pressure in Space. So much space & cardio physiology to unpack here including: - effects of posture, 3g shuttle launch, & microgravity on CVP - change in the relationship between filling pressure (CVP) & LV size - Guyton curves! 1/

New favorite physiology paper: Central Venous Pressure in Space.

So much space & cardio physiology to unpack here including:
- effects of posture, 3g shuttle launch, & microgravity on CVP
- change in the relationship between filling pressure (CVP) & LV size 
- Guyton curves!
1/